GENE ONLINE|News &
Opinion
Blog

BeiGene
BITT’s TNFR2 Antagonist to Enter Clinical Trials In Collaboration with BeiGene
2021-02-20
BeiGene’s Immunotherapy Drug Shines in Phase ESCC Trial
2021-01-31
Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration
2021-01-15
Biotech Duo Revise Co-development & Commercialization Agreement of Intelligent Drug Delivery System
2020-10-08
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
Weekly Cover: The 4th Asia Microbiome Conference
2020-01-08
ESMO Asia 2019 Roundup
2019-12-10
Weekly in Asia|Nov-1
2019-11-19
Weekly in Asia|Nov
2019-11-07
Weekly in Asia 2019|JULY
2019-07-11
Weekly in Asia(0421-0427 )
2019-04-30
Weekly Top 5 in China (0310-0316)
2019-03-19
Weekly Top 5 in China (0127-0202)
2019-01-29
1 2
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top